Danish drugmaker Novo Nordisk is launching its once-daily Wegovy capsule in america on Monday, providing doses of 1.5 milligrams and 4 mg at $149 per thirty days for self-paying sufferers in an intensely aggressive weight-loss drug market.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
